Trends in Inter Partes Review of Life Sciences Patents

Trends in Inter Partes Review of Life Sciences Patents

Publications

Bloomberg BNA's Patent, Trademark & Copyright Journal published an article written by Monica Grewal, James Hill and Kathryn Zalewski, which provides a statistical analysis of inter partes review proceedings before the Patent Trial and Appeal Board and shows that it is not a ''death squad'' for patents.

First available in September 2012 under the America Invents Act, petitions for inter partes review have become a popular and relatively inexpensive staple in patent litigation. Read the full article

Contributors